SkinHealth Systems Inc (STU:V7A0)
€ 0.64 -0.015 (-2.31%) Market Cap: 83.41 Mil Enterprise Value: 226.49 Mil PE Ratio: 0 PB Ratio: 1.71 GF Score: 51/100

Q4 2024 Beauty Health Co Earnings Call Transcript

Mar 12, 2025 / 08:30PM GMT
Release Date Price: €1.3 (+4.00%)

Key Points

Positve
  • The Beauty Health Co (SKIN) exceeded its full-year guidance with net revenue of $33.4 million and adjusted EBITDA of $12.3 million.
  • The company reduced operating expenses by over $30 million, demonstrating strong financial discipline.
  • Consumable sales grew by 8.7% in Q4 2024, with growth across all regions, indicating strong demand for their products.
  • The company successfully implemented a 'good, better, best' pricing strategy, increasing non-Zendeo unit sales.
  • Operational improvements, such as consolidating manufacturing in Long Beach and exiting China production, have reduced costs and improved quality control.
Negative
  • Fourth quarter revenue declined by 13.8% year over year, reflecting a challenging environment for capital equipment purchases.
  • Global equipment sales decreased by 40% in the fourth quarter, particularly impacting international markets.
  • The company is facing macroeconomic uncertainties and high interest rates, which are affecting provider decisions on device purchases.
  • There is a projected decline in sales across all regions for 2025, especially in China due to the transition to a third-party distributor model.
  • Despite improvements, the company still faces challenges with lower device sales and a decline in higher-priced consumable options.
Operator

Good day, and welcome to the Beauty Health Company Fourth Quarter and 2024 Full Year Earnings and Conference Call. All participants will be in listen only mode. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Norberto Aja of Investor Relations. Please go ahead.

Norberto Aja
JCIR - Investor Relations

Thank you, operator, and good afternoon, everyone. Thank you for joining the Beauty Health Companyâs conference call to discuss our fourth quarter and 2024 full year financial results. We will release our results earlier this afternoon, which can be found on our corporate website at beautyhealth.com. Joining me on the call today is Beauty Healthâs Chief Executive Officer, Marla Beck, along with our Chief Financial Officer, Mike Monahan. Before we begin, however, I would like to remind everyone of the companyâs safe harbor language.

Management may make forward looking statements, including guidance and underlying assumptions. Forward looking statements are based on expectations that involve

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot